Health Care·Health Care Equipment·$48.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.76 | N/A | +11.60% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.76 | N/A | +11.60% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized their strategic focus on market expansion.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and expanding our market reach.
Edwards Lifesciences reported a strong EPS performance, exceeding expectations by 11.60%. The stock reacted positively, gaining 0.44% in response to the earnings beat. However, the lack of revenue data and forward guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KIMBERLY CLARK CORP
Apr 21, 2014